12:00 AM
May 21, 2007
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Oxygent perflubron: Phase IIb started

ALLP began a double-blind, placebo-controlled, dose-escalation, French Phase IIb trial in 128 patients undergoing primary coronary artery bypass graft (CABG) surgery under...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >